Thousands in England unable to access weight loss jabs via GP, figures reveal
The article reports that thousands of patients in England are unable to access weight loss injections through their general practitioners (GPs). Doctors have criticized the NHS rollout of the drug Mounjaro (tirzepatide), made by Eli Lilly, as "not fit for purpose." According to the article, GPs were given the green light to prescribe the drug in June, and about 220,000 people with the "greatest need" were expected to receive it on the NHS over the next three years. However, the data reveals that fewer than half of NHS commissioning bodies are currently prescribing the weight loss jabs, leaving many patients unable to access the treatment through their GP. The article highlights the concerns raised by family doctors about the issues surrounding the NHS rollout of this weight loss medication, suggesting that the system is not adequately serving the needs of the target patient population.
Source: For the complete article, please visit the original source link below.
